Myriad Pharmaceuticals preclinical data

In a mouse xenograft model of human colon carcinoma, a single 50 or 75 mg/kg dose of oral MPI-0486348 led to respective 31% and 67% tumor regression rates. MPI-0486348 is a small molecule inhibitor of...